Emerging evidence has demonstrated that long noncoding RNAs (lncRNAs) mediate the
development of esophageal squamous cell carcinoma (ESCC) via various …

This single-arm phase 2 trial (ChiCTR2100046715) examined previously untreated patients
with advanced esophageal squamous cell carcinoma (ESCC) who received four cycles of …

Esophageal cancer (EC) is relatively common; at the time of diagnosis, 50% of cases
present with distant metastases, and most patients are men. This study aimed to examine …

Purpose To evaluate the potential benefits of concurrent chemoradiotherapy (CCRT), and to
establish a nomogram for predicting survival outcomes of elderly patients with synchronous …

Purpose This study aimed to compare the efficacy and safety of combining first-line
chemoimmunotherapy with radiation therapy versus chemoimmunotherapy alone in patients …

Introduction The role of definitive radiotherapy in advanced esophageal squamous cell
carcinoma (ESCC), especially in the metastatic setting, remains unclear. Therefore, we …

Background We aimed to explore the role of local ablative treatment (LAT) in metastatic
esophageal squamous cell cancer (ESCC) patients who received chemotherapy and …

Purpose Initial studies investigating the combination of local and systemic treatments in
advanced esophageal cancer (EC) have conflicting conclusions regarding survival benefits …

Esophageal cancer (EC) remains a leading cause of death worldwide and in Taiwan. The
prognosis of advanced-stage EC is notably poor, and the treatment options are limited …

Introduction For patients with stage IV esophageal cancer, esophageal radiation may be
used selectively for local control and palliation. We aimed to understand patterns of radiation …